For decades, "stem cell therapy" lived at the outer edge of medicine — experimental, expensive, and largely inaccessible to anyone outside of elite sports medicine or advanced clinical trials. That era is over. Stem cell-derived treatments have moved from the frontier into mainstream regenerative medicine, and what was once reserved for professional athletes or biohackers with access to offshore clinics is now available as a personalized, evidence-informed protocol for patients who want to invest seriously in their long-term health and function.

At Évry Aesthetics in Elmhurst, IL, we offer stem cell therapy across multiple modalities — targeted local treatments for joint restoration and hair rejuvenation, and the most comprehensive delivery method of all: intravenous (IV) stem cell-derived therapy , which delivers regenerative signals systemically, reaching every tissue and organ in the body simultaneously. This is not a wellness trend with a science-sounding name. It is science — applied with clinical precision toward the goal of helping you feel and function better, for longer.

What stem cells actually are — and why they decline

Stem cells are the body's master repair cells — capable of differentiating into specialized cell types and secreting the biological signals that drive tissue regeneration across every system in the body. They are the reason a wound heals, why bone remodels after a fracture, and why the body recovers from physical stress so efficiently when we're young.

The problem is biological inevitability: stem cell activity declines with age . By your 30s, the regenerative output of your stem cell population has already meaningfully decreased from its peak. By your 50s, it has declined by an estimated 50–70%. This decline is not confined to one system — it manifests as slower recovery, increased systemic inflammation, reduced immune resilience, diminished energy, compromised joint health, and the progressive functional decline we associate with aging across every organ system in the body.

Stem cell therapy — in its modern, clinically refined forms — addresses this decline not by introducing foreign cells, but by delivering the bioactive signals and growth factors that stem cells produce: exosomes, cytokines, peptides, and microRNA that instruct the body's own resident cells to repair, regenerate, and perform at a higher level.

THE SCIENCE BRIEF

Mesenchymal stem cell-derived exosomes (MSC-Exos)

The most clinically validated stem cell-derived therapy involves exosomes from mesenchymal stem cells — nano-sized vesicles packed with microRNA, growth factors, and bioactive proteins. MSC-Exos modulate immune responses, inhibit inflammatory pathways, promote tissue repair, and stimulate angiogenesis across multiple organ systems. Published research confirms their capacity to attenuate fibrosis, modulate macrophage polarization, suppress autoreactive immune activity, and deliver functional molecules that regulate gene expression and cellular repair — systemically when delivered IV, or locally when injected into targeted tissue.

Why exosomes, not whole cells

Modern stem cell therapy increasingly uses cell-derived products — exosomes and growth factor concentrates — rather than live stem cells themselves. This approach offers a superior safety profile (lower immunogenicity, no risk of uncontrolled cell growth), greater consistency and reproducibility, and the ability to deliver the regenerative benefits of stem cell activity without the regulatory and logistical complexity of live cell transplantation. The therapeutic benefits of MSCs are now understood to arise primarily from their secreted exosomes — not from the cells themselves proliferating in the body.

PRGF-Endoret®: your own stem cell signals

Plasma Rich in Growth Factors, derived from your own blood using the Endoret® protocol, represents the autologous side of stem cell-derived therapy. Your own platelets release concentrated growth factors — EGF, PDGF, IGF-I, and more — that perform the same regenerative signaling function as exogenous stem cell products, with the added benefit of being 100% biocompatible and derived entirely from you. At Évry, PRGF is used in our joint restoration and hair regeneration protocols.

The systemic benefits — what patients report and what the science supports

Because IV stem cell-derived therapy reaches the body systemically, its benefits extend across multiple dimensions of health and function. This is why it sits at the intersection of longevity medicine and everyday wellness — not as a single-condition treatment, but as a platform for comprehensive cellular renewal.

• Energy and vitality — stem cell-derived growth factors support mitochondrial health, the cellular energy-production system that declines measurably with age. Improved energy levels, stamina, and cognitive clarity are among the most consistently reported patient outcomes following IV therapy.

• Systemic inflammation reduction — chronic low-grade inflammation is one of the primary drivers of accelerated biological aging across every organ system. MSC-derived exosomes modulate inflammatory pathways systemically — with downstream benefits for joint comfort, metabolic function, immune performance, and recovery capacity.

• Immune modulation and resilience — published research demonstrates that MSC-derived exosomes support immune regulation by modulating macrophage polarization, suppressing autoreactive immune activity, and calibrating inflammatory response. Patients frequently report improved resistance to illness and faster recovery when under physical or environmental stress.

• Joint health and mobility — the systemic anti-inflammatory environment created by IV therapy complements and amplifies our targeted joint injection protocols. For patients also receiving PRGF joint injections at Évry, IV therapy supports the broader tissue environment in which local regeneration is occurring.

• Recovery and resilience — whether from exercise, illness, travel, or the cumulative wear of daily life, stem cell-derived therapy supports faster cellular recovery and greater physiological resilience over time. This is the dimension most valued by active patients and those in high-demand professional or physical environments.

• Hair regeneration support — systemic delivery of regenerative signals supports follicular health and the cellular environment in which local hair restoration treatments operate — making IV therapy a meaningful complement to our exosome hair restoration protocol for patients pursuing comprehensive results.

How we build your protocol

Stem cell therapy at Évry begins with a comprehensive consultation — not a menu. We assess your health history, functional concerns, and longevity priorities before recommending any treatment pathway. A typical Évry regenerative protocol might begin with IV stem cell-derived therapy to establish a systemic baseline of cellular health, layered with targeted local treatments — PRGF joint injections for patients managing mobility or discomfort, and exosome microneedling for hair restoration. Each treatment amplifies the others: the systemic environment created by IV therapy makes local treatments more effective, and the local treatments address specific concerns that systemic therapy alone cannot target precisely.

This is a different kind of practice — one that asks not just "what hurts?" but "how do you want to function, and for how long?"

If you're in Elmhurst, Oak Brook, Wheaton, Lombard, or the greater Chicago area and ready to think about your health as a whole system — rather than a list of separate concerns — stem cell therapy at Évry is where that conversation begins.

Book your complimentary stem cell therapy consultation

Évry Aesthetics · 597 N York St, Elmhurst, IL · (630) 333-4285